rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1997-1-31
|
pubmed:abstractText |
Previous studies of labor analgesia using subarachnoid sufentanil (alone or with adjuvants) have focused on women in the early first stage of labor. This study prospectively evaluated analgesia and side effects of subarachnoid sufentanil (10 micrograms) plus bupivacaine (2.5 mg) in parturients with cervical dilation of 7 cm or more.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0146-521X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
424-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8896002-Adult,
pubmed-meshheading:8896002-Analgesia, Obstetrical,
pubmed-meshheading:8896002-Blood Pressure,
pubmed-meshheading:8896002-Bupivacaine,
pubmed-meshheading:8896002-Female,
pubmed-meshheading:8896002-Humans,
pubmed-meshheading:8896002-Injections, Spinal,
pubmed-meshheading:8896002-Labor Stage, First,
pubmed-meshheading:8896002-Pregnancy,
pubmed-meshheading:8896002-Prospective Studies,
pubmed-meshheading:8896002-Pruritus,
pubmed-meshheading:8896002-Subarachnoid Space,
pubmed-meshheading:8896002-Sufentanil
|
pubmed:articleTitle |
Analgesic efficacy and side effects of subarachnoid sufentanil-bupivacaine administered to women in advanced labor.
|
pubmed:affiliation |
Department of Anesthesiology, University of Vermont College of Medicine, Burlington, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|